Ronald Vogels

机构：Johnson & Johnson (United States), Johnson & Johnson (Israel), Johnson & Johnson (Netherlands) · ORCID：0009-0007-0818-6160

发表论文 65 篇 · 总被引 7211 次 · h-index 36

代表论文

• Highly Conserved Protective Epitopes on Influenza B Viruses (2012 · Science · 被引 926)
• A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses (2011 · Science · 被引 871)
• Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D (2007 · Journal of Virology · 被引 522)
• Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity (2003 · Journal of Virology · 被引 475)
• Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses (2020 · npj Vaccines · 被引 377)
• Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein (2005 · The Journal of Immunology · 被引 368)